A detailed history of Principia Wealth Advisory, LLC transactions in Incyte Corp stock. As of the latest transaction made, Principia Wealth Advisory, LLC holds 3,014 shares of INCY stock, worth $263,152. This represents 0.17% of its overall portfolio holdings.

Number of Shares
3,014
Previous 3,000 0.47%
Holding current value
$263,152
Previous $177 Million 16.24%
% of portfolio
0.17%
Previous 0.17%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$55.17 - $71.22 $772 - $997
14 Added 0.47%
3,014 $205 Million
Q1 2025

Apr 11, 2025

SELL
$60.0 - $75.26 $360 - $451
-6 Reduced 0.2%
3,000 $177 Million
Q4 2024

Apr 11, 2025

BUY
$65.08 - $83.38 $195,630 - $250,640
3,006 New
3,006 $208 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $19.4B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Principia Wealth Advisory, LLC Portfolio

Follow Principia Wealth Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principia Wealth Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Principia Wealth Advisory, LLC with notifications on news.